Home / 2022 / August (page 30)

Monthly Archives: August 2022

Ville Parpala Named Regional Sales Manager, Scandinavia for Nikkiso Clean Energy and Industrial Gases Group Europe

TEMECULA, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Ville Parpala has been named Regional Sales Manager for Scandinavia. Ville brings a strong European sales and business development background with […]

Read More »

Stefan Kuijs Named Product Manager for LNG & Hydrogen – The Netherlands – for Nikkiso Clean Energy and Industrial Gases Group Europe

TEMECULA, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Stefan Kuijs has been named Product Manager for LNG & Hydrogen for Nikkiso Integrated Cryogenic Solutions serving the Netherlands. A mechanical […]

Read More »

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – TGTX

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TG Therapeutics, Inc. (NASDAQ: TGTX) between January 15, 2020 and May 31, 2022, both dates inclusive (the “Class Period”), of the important September 16, 2022 lead plaintiff deadline. SO WHAT: If you […]

Read More »

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages MINISO Group Holding Limited Investors to Inquire About Securities Class Action Investigation – MNSO

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of MINISO Group Holding Limited (NYSE: MNSO) resulting from allegations that MINISO may have issued materially misleading business information to the investing public. SO WHAT: If you […]

Read More »

Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results DREAM enrollment complete, 12-month clinical data expected in fall of 2023 Mont-Saint-Guibert, Belgium – August 8, 2022, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative […]

Read More »
Scroll To Top